Patent ID: 7306804

Claim:
A method of treating an HIV-infected human subject, the method comprising the steps of administering to said subject a pharmaceutically acceptable composition which delivers one or more peptides having peptide sequences selected from the group consisting of the following groups of peptide sequences or combinations thereof: a) SEQ ID NO:26, 27, 28, 29, 30, 31, 32, 33 or 34; b) SEQ ID NO:20, 21, 22, 23, 24, 25 or 40; c) SEQ ID NO:1, 2 or 3; d) SEQ ID NO:4, 5, 6, or 7; e) SEQ ID NO:8, 9, 10, 11, 12, 13, 14, 15 or 38; and f) SEQ ID NO:16, 17, 18, 19 or 20; wherein the delivery of said peptide(s) promotes the induction of an HIV-directed cytotoxic T-Iymphocyte response.